Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 20

Showing 20 citing articles:

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 57
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
Cytokine (2022) Vol. 157, pp. 155934-155934
Open Access | Times Cited: 29
Activation of TLR4 by viral glycoproteins: A double-edged sword?
Emily A. Halajian, Emmanuelle V. LeBlanc, Katrina Gee, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
Precise genome editing without exogenous donor DNA via retron editing system in human cells
Xiangfeng Kong, Zikang Wang, Renxia Zhang, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 899-902
Open Access | Times Cited: 34
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, et al.
Cell Reports (2022) Vol. 39, Iss. 11, pp. 110945-110945
Open Access | Times Cited: 16
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir
Brian Epling, Joseph M. Rocco, Kristin L. Boswell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
Oleksandr Dmytrenko, Kory J. Lavine
Viruses (2022) Vol. 14, Iss. 6, pp. 1137-1137
Open Access | Times Cited: 10
Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
Hatixhe Latifi-Pupovci
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113368-113368
Open Access | Times Cited: 10
Liposome encapsulated clodronate mediated elimination of pathogenic macrophages and microglia: A promising pharmacological regime to defuse cytokine storm in COVID-19
Sowbarnika Ravichandran, Nivethitha Manickam, Mahesh Kandasamy
Medicine in Drug Discovery (2022) Vol. 15, pp. 100136-100136
Open Access | Times Cited: 9
Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
Yu Zeng, Yonghua Cai, Peng Chai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses
Thien‐Phong Vu Manh, Carla Gouin, Julien De Wolf, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in Mice
Irfan Ullah, Fanny Escudié, Ivan Scandale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19
Keyla Santos Guedes de Sá, Luana A. Amaral, Camila Carla da Silva Caetano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses
Thien‐Phong Vu Manh, Carla Gouin, Julien De Wolf, et al.
Research Square (Research Square) (2024)
Open Access
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not antigen-experienced vaccinees
Julie Van Coillie, Tamás Pongrácz, Johann Rahmöller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
A humanized “new-trophil” mouse to study early inflammatory processes
Florian Douam, Alexander Ploß
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 49
Open Access | Times Cited: 3
Characterizing Macrophages Diversity in COVID-19 Patients Using Deep Learning
Mario Flores, Karla Paniagua, Wenjian Huang, et al.
Genes (2022) Vol. 13, Iss. 12, pp. 2264-2264
Open Access | Times Cited: 2
What triggers severe COVID? Infected immune cells hold clues
Smriti Mallapaty
Nature (2022) Vol. 604, Iss. 7905, pp. 231-231
Open Access | Times Cited: 1
CASP4/11 contributes to pulmonary inflammation and disease exacerbation in COVID-19
Tamara Silva Rodrigues, Camila Carla da Silva Caetano, Keyla Santos Guedes de Sá, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
COVID-19 induced ARDS: immunopathology and therapeutics
Sneha Das, Tamanna Sharma, Asha Bhardwaj, et al.
Exploration of Immunology (2023), pp. 255-275
Open Access
Page 1

Scroll to top